标普生物科技LOF(161127)
动态评分： 4.62分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2018-12-31 | FATE | Fate Therapeutics Inc | 39.17 | 0.32% |
| 2018-12-31 | ALLK | Allakos Inc | 33.36 | 0.28% |
| 2018-12-31 | CTMX | CytomX Therapeutics Inc | 34.32 | 0.28% |
| 2018-12-31 | RIGL | Rigel Pharmaceuticals Inc | 33.63 | 0.28% |
| 2018-12-31 | SRNE | Sorrento Therapeutics Inc | 32.75 | 0.27% |
| 2018-12-31 | EPZM | Epizyme Inc | 30.93 | 0.26% |
| 2018-12-31 | DCPH | Deciphera Pharmaceuticals Inc | 29.7 | 0.25% |
| 2018-12-31 | PRTA | Prothena Corp plc | 25.92 | 0.21% |
| 2018-12-31 | ARQL | ArQule Inc | 24.54 | 0.2% |
| 2018-12-31 | MGNX | MacroGenics Inc | 24.84 | 0.2% |
| 2018-12-31 | ATNX | Athenex Inc | 22.96 | 0.19% |
| 2018-12-31 | INO | Inovio制药 | 23.32 | 0.19% |
| 2018-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 21.9 | 0.18% |
| 2018-12-31 | PDLI | PDL BioPharma Inc | 22.01 | 0.18% |
| 2018-12-31 | RYTM | Rhythm Pharmaceuticals Inc | 20.02 | 0.17% |
| 2018-12-31 | FPRX | Five Prime Therapeutics Inc | 19.26 | 0.16% |
| 2018-12-31 | GLYC | GlycoMimetics Inc | 19.75 | 0.16% |
| 2018-12-31 | KURA | Kura Oncology Inc | 17.87 | 0.15% |
| 2018-12-31 | LXRX | 莱斯康制药 | 18.2 | 0.15% |
| 2018-12-31 | AKBA | Akebia Therapeutics Inc | 17.48 | 0.14% |
公告&资料